Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab

被引：0
|
作者：
Yosuke Masamoto
Kazuki Taoka
Hiroaki Maki
Mineo Kurokawa
机构：
[1] The University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
[2] The University of Tokyo Hospital,Department of Cell Therapy and Transplantation Medicine
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
Follicular lymphoma; Obinutuzumab; Infusion-related reactions; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2795 / 2797
页数：2
相关论文
共 50 条
  • [21] Assessment of Bone Marrow Involvement by FDG-PET in Patients with Follicular Lymphoma
    El Najjar, Inas
    Szyszko, Teresa
    Mc Dowell, Amy
    Matthews, Janet
    Gribben, John G.
    Montoto, Silvia
    BLOOD, 2012, 120 (21)
  • [22] The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma
    Kato, Daisuke
    Yoshioka, Satoshi
    Yabushita, Tomohiro
    Shimomura, Yoshimitsu
    Ono, Yuichiro
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Matsushita, Akiko
    Hashimoto, Hisako
    Ishikawa, Takayuki
    BLOOD, 2016, 128 (22)
  • [23] ETOPOSIDE INFUSION-RELATED REACTIONS IN PEDIATRIC ONCOLOGY PATIENTS
    Rayar, M.
    Dupuis, L.
    Atkinson, A.
    Shaikh, F.
    Taylor, T.
    Ross, S.
    Alexander, S.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S352 - S353
  • [24] Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels
    Lujan, Juliana Velez
    Lengerke-Diaz, Paula A.
    Jacobs, Chaja
    Moreno-Cortes, Eider F.
    Ramirez-Segura, Cesar A.
    Choi, Michael Y.
    McCarthy, Colin
    Heinen, Alaina
    Kipps, Thomas J.
    Castro, Januario E.
    HAEMATOLOGICA, 2020, 105 (01) : E22 - E25
  • [25] Infusion-related reactions in Black/African American and Hispanic/Latino patients treated with ocrelizumab administered as a shorter infusion
    Amjad, F.
    Okai, A.
    Obeidat, A. Z.
    Pei, J.
    Acosta, J.
    Ndrio, J.
    Magrini, F.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 586 - 586
  • [26] Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma
    Rajnai, Hajnalka
    Boedoer, Csaba
    Balogh, Zsofia
    Gagyi, Eva
    Csomor, Judit
    Krenacs, Tibor
    Toth, Erika
    Matolcsy, Andras
    HISTOPATHOLOGY, 2012, 60 (6B) : E66 - E75
  • [27] Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma
    Rajnai, H.
    Bodor, C.
    Balogh, Z.
    Gagyi, E.
    Csomor, J.
    Krenacs, T.
    Toth, E.
    Matolcsy, A.
    VIRCHOWS ARCHIV, 2011, 459 : S33 - S33
  • [28] Flow cytometry to detect bone marrow involvement by follicular lymphoma
    Aren, Merce
    Marce, Silvia
    Jurado, Rebeca
    Tapia, Gustavo
    Puigdefabregues, Lluis
    Raya, Minerva
    Cortes, Montserrat
    Garcia-Caro, Montse
    Junca, Jordi
    Mozas, Pablo
    Vinets, Esther
    Cabezon, Marta
    Plensa, Esther
    Miljkovic, Milos
    Sancho, Juan-Manuel
    Navarro, Jose-Tomas
    Zamora, Lurdes
    Sorigue, Marc
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2022, 102 (06) : 427 - 439
  • [29] PURGING WITH CHLORAMBUCIL TO PREVENT INFUSION-RELATED REACTIONS BEFORE OBINUTUZUMAB ADMINISTRATION: A MONOCENTRIC PILOT EXPERIENCE.
    Fresa, A.
    Autore, F.
    Innocenti, I.
    Corbingi, A.
    Morelli, F.
    Tomasso, A.
    Laurenti, L.
    HAEMATOLOGICA, 2019, 104 : 103 - 103
  • [30] Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
    Richard Greil
    Alessandra Tedeschi
    Carol Moreno
    Bertrand Anz
    Loree Larratt
    Martin Simkovic
    Devinder Gill
    John G. Gribben
    Ian W. Flinn
    Zhengyuan Wang
    Leo W. K. Cheung
    Aaron N. Nguyen
    Cathy Zhou
    Lori Styles
    Fatih Demirkan
    Annals of Hematology, 2021, 100 : 1733 - 1742
12345